VLEUGELS PHARMACEUTICAL SERVICES: what changed
VLEUGELS PHARMACEUTICAL SERVICES
Largest movements
- Receivables within one year +€6,656
up €6,656 (+402%), from €1,658 to €8,314
- Cash -€6,218
down €6,218 (-24.5%), from €25,409 to €19,191
mainly Contributions, distributions and other (-€42,163) and Receivables within one year (-€6,656)
- Tangible fixed assets +€2,541
up €2,541 (+33.5%), from €7,593 to €10,134
of which Furniture and vehicles: +€3,465
- Other debts +€23,134
up €23,134 (+1,104%), from €2,096 to €25,230
- Reserves -€22,143
down €22,143 (-100%), from €22,143 to €0
- Tax, wage and social debts +€1,814
up €1,814 (+21.5%), from €8,444 to €10,258
- Gross operating margin +€16,891
up €16,891 (+152%), from €11,128 to €28,020
- Taxes +€3,309
up €3,309 (+131%), from €2,527 to €5,836
- Depreciation +€671
up €671 (+72.7%), from €924 to €1,595
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €34,659 | €37,638 | +€2,979 | +8.6% |
| Fixed assets | 21/28 | €7,593 | €10,134 | +€2,541 | +33.5% |
| Tangible fixed assets | 22/27 | €7,593 | €10,134 | +€2,541 | +33.5% |
| Plant, machinery and equipment | 23 | €7,593 | €6,669 | -€924 | -12.2% |
| Furniture and vehicles | 24 | - | €3,465 | +€3,465 | |
| Current assets | 29/58 | €27,067 | €27,505 | +€438 | +1.6% |
| Amounts receivable within one year | 40/41 | €1,658 | €8,314 | +€6,656 | +402% |
| Trade receivables | 40 | €1,658 | €8,314 | +€6,656 | +402% |
| Cash at bank and in hand | 54/58 | €25,409 | €19,191 | -€6,218 | -24.5% |
| Total equity and liabilities | 10/49 | €34,659 | €37,638 | +€2,979 | +8.6% |
| Equity | 10/15 | €23,143 | €1,000 | -€22,143 | -95.7% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Reserves | 13 | €22,143 | €0 | -€22,143 | -100% |
| Distributable reserves | 133 | €22,143 | €0 | -€22,143 | -100% |
| Profit (loss) carried forward | 14 | - | €0 | = | |
| Amounts payable | 17/49 | €11,516 | €36,638 | +€25,122 | +218% |
| Amounts payable within one year | 42/48 | €11,307 | €36,380 | +€25,072 | +222% |
| Trade debts | 44 | €768 | €892 | +€124 | +16.2% |
| Suppliers | 440/4 | €768 | €892 | +€124 | +16.2% |
| Taxes, remuneration and social security | 45 | €8,444 | €10,258 | +€1,814 | +21.5% |
| Taxes | 450/3 | €8,444 | €10,258 | +€1,814 | +21.5% |
| Other amounts payable | 47/48 | €2,096 | €25,230 | +€23,134 | +1,104% |
| Accrued charges and deferred income | 492/3 | €209 | €259 | +€50 | +23.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €924 | €1,595 | +€671 | +72.7% |
| Other operating charges | 640/8 | €359 | €186 | -€173 | -48.2% |
| Gross operating margin | 9900 | €11,128 | €28,020 | +€16,891 | +152% |
| Operating profit (loss) | 9901 | €9,846 | €26,239 | +€16,393 | +166% |
| Financial charges | 65/66B | €337 | €383 | +€46 | +13.7% |
| Recurring financial charges | 65 | €337 | €383 | +€46 | +13.7% |
| Profit (loss) for the period before taxes | 9903 | €9,509 | €25,856 | +€16,347 | +172% |
| Income taxes | 67/77 | €2,527 | €5,836 | +€3,309 | +131% |
| Profit (loss) for the period | 9904 | €6,982 | €20,020 | +€13,038 | +187% |
| Profit (loss) for the period to be appropriated | 9905 | €6,982 | €20,020 | +€13,038 | +187% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.